MorphoSys AG (MOR)
19.00
-0.34
(-1.76%)
USD |
NASDAQ |
May 17, 16:00
18.98
-0.02
(-0.11%)
After-Hours: 20:00
MorphoSys Cash from Investing (Quarterly)
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | 25.51M |
| March 31, 2023 | 10.61M |
| June 30, 2022 | 98.70M |
| March 31, 2022 | 129.25M |
| December 31, 2021 | 19.06M |
| September 30, 2021 | -1.355B |
| June 30, 2021 | 312.79M |
| March 31, 2021 | 40.00M |
| December 31, 2020 | -226.78M |
| September 30, 2020 | 35.28M |
| June 30, 2020 | -813.05M |
| March 31, 2020 | |
| December 31, 2019 | 30.27M |
| September 30, 2019 | -3.123M |
| June 30, 2019 | 30.95M |
| March 31, 2019 | 30.88M |
| December 31, 2018 | -62.83M |
| September 30, 2018 | 45.19M |
| June 30, 2018 | -200.41M |
| March 31, 2018 | 8.163M |
| December 31, 2017 | -12.41M |
| September 30, 2017 | 36.75M |
| June 30, 2017 | -42.00M |
| March 31, 2017 | 54.95M |
| December 31, 2016 | -55.19M |
| Date | Value |
|---|---|
| September 30, 2016 | -28.50M |
| June 30, 2016 | -62.93M |
| March 31, 2016 | 57.20M |
| December 31, 2015 | 92.19M |
| September 30, 2015 | -26.82M |
| June 30, 2015 | 31.86M |
| March 31, 2015 | -1.498M |
| December 31, 2014 | -42.40M |
| September 30, 2014 | 20.78M |
| June 30, 2014 | 5.452M |
| March 31, 2014 | -12.42M |
| December 31, 2013 | -30.63M |
| September 30, 2013 | -233.09M |
| June 30, 2013 | 21.99M |
| March 31, 2013 | -15.72M |
| December 31, 2012 | -3.901M |
| September 30, 2012 | 1.254M |
| June 30, 2012 | 12.27M |
| March 31, 2012 | -25.16M |
| December 31, 2011 | -2.294M |
| September 30, 2011 | 2.479M |
| June 30, 2011 | -17.59M |
| March 31, 2011 | -7.821M |
| December 31, 2010 | 9.626M |
| September 30, 2010 | 21.46M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-1.355B
Minimum
Sep 2021
312.79M
Maximum
Jun 2021
-118.97M
Average
27.89M
Median
Cash from Investing (Quarterly) Benchmarks
| Novartis AG | -899.00M |
| Immatics NV | -262.66M |
| Affimed NV | 1.755M |
| InflaRx NV | 29.27M |
| BioNTech SE | -2.503B |
Cash from Investing (Quarterly) Related Metrics
| Free Cash Flow Yield | -18.17% |